← All stocks

MYOMO, INC.

MYO Net selling

CIK 0001369290 #4562 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$70.73K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$70.73K

3 of 3 sales

Net

−$70.73K

−$70.73K against sales at will

By person

10 insiders · 3 transactions

4.8×

Paul R. Gudonis holds only 4.8 times base salary in stock. $1.82M of shares against $375.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul R. Gudonis last reported holding, valued at $1.27, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kovelman Harry

Chief Medical Officer

—

$49.58K (2)

−$49.58K

90,245

0.2278%

$114.69K

−27.5%

Morris Milton Mayo

Director

—

$21.15K (1)

−$21.15K

208,391

0.5261%

$264.84K

+81.3%

Manko Joseph M. Jr.

Director

—

2,388,479

6.03%

$3.04M

+13.3%

GUDONIS PAUL R

Chief Executive Officer

—

1,434,679

3.62%

$1.82M

+41.8%

KIRK THOMAS F

Director

—

772,569

1.95%

$981.86K

+210.9%

HENRY DAVID A

Chief Financial Officer

—

470,163

1.19%

$597.53K

+23.3%

Getz Heather C

Director

—

210,458

0.5314%

$267.47K

+1,649%

Crowley Thomas Aloysius Jr.

Director

—

154,931

0.3912%

$196.90K

+267.8%

Mitchell Micah

Chief Commercial Officer

—

130,738

0.3301%

$166.15K

−31.0%

FEBBO WILLIAM J

Director

—

123,704

0.3123%

$157.22K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Kovelman Harry

11 Sep 2026

Chief Medical Officer

Sell

15,488

$1.27

$19.68K

Morris Milton Mayo

2 Sep 2026

Director

Sell

15,000

$1.41

$21.15K

Kovelman Harry

20 Aug 2026

Chief Medical Officer

Sell

17,250

$1.73

$29.90K

Show all 3 transactions →

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 0

History held since 13 Jun 2017